Other OTC - Delayed Quote • USD
SQZ Biotechnologies Company (SQZB)
At close: May 17 at 3:23 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
12,196.0000
21,029.0000
27,098.0000
20,998.0000
Operating Expense
72,963.0000
96,854.0000
95,867.0000
72,056.0000
Operating Income
-60,767.0000
-75,825.0000
-68,769.0000
-51,058.0000
Net Non Operating Interest Income Expense
1,624.0000
1,223.0000
36.0000
550.0000
Other Income Expense
-12,500.0000
-4,862.0000
-8.0000
-13.0000
Pretax Income
-71,643.0000
-79,464.0000
-68,741.0000
-50,521.0000
Net Income Common Stockholders
-71,643.0000
-79,464.0000
-68,741.0000
-50,521.0000
Diluted NI Available to Com Stockholders
-71,643.0000
-79,464.0000
-68,741.0000
-50,521.0000
Basic EPS
-2.43
-2.76
-2.49
-9.35
Diluted EPS
-2.43
-2.76
-2.49
-9.35
Basic Average Shares
29,478.9830
28,812.9040
27,578.8440
5,401.8950
Diluted Average Shares
29,478.9830
28,812.9040
27,578.8440
5,401.8950
Total Operating Income as Reported
-73,193.0000
-80,684.0000
-68,769.0000
-51,058.0000
Total Expenses
72,963.0000
96,854.0000
95,867.0000
72,056.0000
Net Income from Continuing & Discontinued Operation
-71,643.0000
-79,464.0000
-68,741.0000
-50,521.0000
Normalized Income
-59,217.0000
-74,605.0000
-68,741.0000
-50,521.0000
Interest Income
1,624.0000
1,223.0000
36.0000
550.0000
Net Interest Income
1,624.0000
1,223.0000
36.0000
550.0000
EBIT
-60,767.0000
-75,825.0000
-68,769.0000
-51,058.0000
EBITDA
-49,315.0000
-64,141.0000
-57,739.0000
-40,115.0000
Reconciled Depreciation
11,452.0000
11,684.0000
11,030.0000
10,943.0000
Net Income from Continuing Operation Net Minority Interest
-71,643.0000
-79,464.0000
-68,741.0000
-50,521.0000
Total Unusual Items Excluding Goodwill
-12,426.0000
-4,859.0000
--
--
Total Unusual Items
-12,426.0000
-4,859.0000
--
--
Normalized EBITDA
-36,889.0000
-59,282.0000
-57,739.0000
-40,115.0000
12/31/2020 - 10/30/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LIANY LianBio
0.3256
+7.73%
JWCTF JW (Cayman) Therapeutics Co. Ltd
0.3000
+10.99%
IXC.AX Invex Therapeutics Ltd
0.0760
0.00%
ABRT.CN Albert Labs International Corp.
0.0150
0.00%
BRIBF Brii Biosciences Limited
0.1832
+1.22%
PTCHF PureTech Health plc
2.8300
+4.81%
S1RP34.SA Sarepta Therapeutics, Inc.
33.21
-2.64%
MSSV Meso Numismatics, Inc.
0.0360
-3.81%
GNCAQ Genocea Biosciences, Inc.
0.0000
0.00%
ISCO International Stem Cell Corporation
0.0900
0.00%